- Home
- MEDP
as 07-26-2024 4:00pm EST
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
| Founded: | 1992 | Country: | United States |
| Employees: | N/A | City: | CINCINNATI |
| Market Cap: | 11.8B | IPO Year: | 2016 |
| Target Price: | $428.14 | AVG Volume (30 days): | 323.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 10.63 | EPS Growth: | 27.31 |
| 52 Week Low/High: | $227.21 - $459.77 | Next Earning Date: | 07-22-2024 |
| Revenue: | $2,030,048,000 | Revenue Growth: | 21.36% |
| Revenue Growth (this year): | 17.35% | Revenue Growth (next year): | 16.22% |
Stock Insider Trading Activity of Medpace Holdings Inc. (MEDP)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| BURWIG SUSAN E | MEDP | Exec. VP, Operations | Jun 5 '24 | Sell | $401.20 | 7,681 | $3,081,617.20 | 7,500 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | May 24 '24 | Sell | $395.49 | 5,695 | $2,252,315.55 | 654,656 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | May 24 '24 | Sell | $395.22 | 3,987 | $1,575,742.14 | 660,351 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | May 22 '24 | Sell | $400.00 | 55 | $22,000.00 | 664,338 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | May 20 '24 | Sell | $400.19 | 4,020 | $1,608,763.80 | 664,393 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | May 15 '24 | Sell | $405.13 | 32,282 | $13,078,406.66 | 675,473 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | May 15 '24 | Sell | $403.09 | 7,060 | $2,845,815.40 | 668,413 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | May 10 '24 | Sell | $402.89 | 4,956 | $1,996,722.84 | 707,755 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | May 8 '24 | Sell | $400.58 | 4,782 | $1,915,573.56 | 716,197 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | May 8 '24 | Sell | $400.17 | 3,486 | $1,394,992.62 | 712,711 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | May 6 '24 | Sell | $401.73 | 24,372 | $9,790,963.56 | 749,011 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | May 6 '24 | Sell | $404.48 | 28,032 | $11,338,383.36 | 720,979 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | May 1 '24 | Sell | $401.56 | 12,934 | $5,193,777.04 | 776,779 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | May 1 '24 | Sell | $400.44 | 3,396 | $1,359,894.24 | 773,383 | SEC Form 4 |
| BURWIG SUSAN E | MEDP | Exec. VP, Operations | Mar 15 '24 | Sell | $403.00 | 102 | $41,106.00 | 15,181 | SEC Form 4 |
| Keating Ashley M. | MEDP | Director | Mar 14 '24 | Sell | $409.87 | 250 | $102,467.50 | 250 | SEC Form 4 |
| Keating Ashley M. | MEDP | Director | Mar 7 '24 | Sell | $415.00 | 472 | $195,880.00 | 0 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | Mar 6 '24 | Sell | $412.98 | 100,000 | $41,298,000.00 | 4,833,019 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | Mar 6 '24 | Sell | $410.74 | 75,000 | $30,805,500.00 | 4,758,019 | SEC Form 4 |
| Troendle August J. | MEDP | CEO | Mar 6 '24 | Sell | $408.71 | 25,000 | $10,217,750.00 | 4,733,019 | SEC Form 4 |
| Medpace Investors, LLC | MEDP | 10% Owner | Mar 6 '24 | Sell | $412.98 | 100,000 | $41,298,000.00 | 4,833,019 | SEC Form 4 |
| Medpace Investors, LLC | MEDP | 10% Owner | Mar 6 '24 | Sell | $410.74 | 75,000 | $30,805,500.00 | 4,758,019 | SEC Form 4 |
| Medpace Investors, LLC | MEDP | 10% Owner | Mar 6 '24 | Sell | $408.71 | 25,000 | $10,217,750.00 | 4,733,019 | SEC Form 4 |
| GEIGER JESSE J | MEDP | President | Mar 4 '24 | Sell | $403.03 | 22,321 | $8,996,032.63 | 3,824 | SEC Form 4 |
| Medpace Investors, LLC | MEDP | 10% Owner | Mar 4 '24 | Sell | $403.12 | 50,000 | $20,156,000.00 | 4,983,019 | SEC Form 4 |
Latest Medpace Holdings Inc. News
MEDP Breaking Stock News: Dive into MEDP Ticker-Specific Updates for Smart Investing
Morningstar Research
a day ago
Analyst Report: Medpace Holdings, Inc.
Simply Wall St.
2 days ago
Medpace Holdings, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
MT Newswires
2 days ago
UBS Adjusts Medpace Holdings Price Target to $420 From $480, Maintains Buy Rating
MT Newswires
2 days ago
Deutsche Bank Adjusts Medpace Holdings Price Target to $336 From $395, Maintains Hold Rating
Simply Wall St.
3 days ago
Medpace Holdings Second Quarter 2024 Earnings: EPS Beats Expectations
GuruFocus.com
3 days ago
Decoding Medpace Holdings Inc (MEDP): A Strategic SWOT Insight
Thomson Reuters StreetEvents
3 days ago
Q2 2024 Medpace Holdings Inc Earnings Call
Argus Research
3 days ago
MEDP: Lowering target price to $375.00
Compare MEDP vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MEDP Medpace Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.